The store will not work correctly when cookies are disabled.
5-(4-Methoxy-phenyl)-2,3-dihydro-imidazo[2,1-a]isoquinoline
ID: ALA309194
PubChem CID: 9993602
Max Phase: Preclinical
Molecular Formula: C18H16N2O
Molecular Weight: 276.34
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(C2=Cc3ccccc3C3=NCCN23)cc1
Standard InChI: InChI=1S/C18H16N2O/c1-21-15-8-6-13(7-9-15)17-12-14-4-2-3-5-16(14)18-19-10-11-20(17)18/h2-9,12H,10-11H2,1H3
Standard InChI Key: UCSNADLMSSLSFX-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 24 0 0 0 0 0 0 0 0999 V2000
6.8500 -4.3667 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.3375 -4.6667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8792 -3.7792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3667 -3.4542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8167 -4.3542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3375 -5.2667 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8375 -3.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4792 -3.7792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7792 -4.3000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7750 -3.2667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3667 -4.6667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3667 -5.2667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6750 -3.7792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3667 -3.2625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3792 -4.3000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2875 -4.6292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2750 -3.7792 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.3250 -3.4292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6917 -3.3542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7750 -4.3167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7917 -3.7167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 1 0
4 3 2 0
5 2 1 0
6 2 2 0
7 4 1 0
8 3 1 0
9 8 2 0
10 8 1 0
11 1 1 0
12 11 1 0
13 14 1 0
14 10 2 0
15 9 1 0
16 5 1 0
17 13 1 0
18 7 1 0
19 17 1 0
20 16 2 0
21 18 2 0
12 6 1 0
7 5 2 0
13 15 2 0
20 21 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 276.34 | Molecular Weight (Monoisotopic): 276.1263 | AlogP: 3.27 | #Rotatable Bonds: 2 |
Polar Surface Area: 24.83 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 7.20 | CX LogP: 2.90 | CX LogD: 2.69 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.84 | Np Likeness Score: -0.22 |
References
1. Houlihan WJ, Munder PG, Handley DA, Cheon SH, Parrino VA.. (1995) Antitumor activity of 5-aryl-2,3-dihydroimidazo[2,1-a]isoquinolines., 38 (2): [PMID:7830265] [10.1021/jm00002a004] |